Context Therapeutics has been added to the Russell 2000 and 3000 indexes. However, there is some uncertainty as other companies, including Relmada Therapeutics and Avalo Therapeutics, are also reported to have joined these indexes. The addition of Context Therapeutics to the indexes appears to be confirmed by multiple outlets, despite the conflicting reports about other companies.